| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:46 UTC |
|---|
| Update Date | 2020-02-26 21:39:19 UTC |
|---|
| HMDB ID | HMDB0013995 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Hydroxycelecoxib |
|---|
| Description | Hydroxycelecoxib is a metabolite of celecoxib and is only found in individuals that have used or taken this drug (PMID: 10681375 ). Hydroxycelecoxib belongs to the family of phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton which consists of a pyrazole bound to a phenyl group. Celecoxib (trade name: Celebrex) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation, and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. Celecoxib is available by prescription in capsule form (Wikipedia). |
|---|
| Structure | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(CO)C=C1)C(F)(F)F InChI=1S/C17H14F3N3O3S/c18-17(19,20)16-9-15(12-3-1-11(10-24)2-4-12)23(22-16)13-5-7-14(8-6-13)27(21,25)26/h1-9,24H,10H2,(H2,21,25,26) |
|---|
| Synonyms | | Value | Source |
|---|
| 4'-Hydroxycelecoxib | HMDB | | 4’-Hydroxycelecoxib | HMDB | | Hydroxycelecoxib | HMDB |
|
|---|
| Chemical Formula | C17H14F3N3O3S |
|---|
| Average Molecular Weight | 397.372 |
|---|
| Monoisotopic Molecular Weight | 397.070796634 |
|---|
| IUPAC Name | 4-{5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl}benzene-1-sulfonamide |
|---|
| Traditional Name | 4-{5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl}benzenesulfonamide |
|---|
| CAS Registry Number | 170571-00-3 |
|---|
| SMILES | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(CO)C=C1)C(F)(F)F |
|---|
| InChI Identifier | InChI=1S/C17H14F3N3O3S/c18-17(19,20)16-9-15(12-3-1-11(10-24)2-4-12)23(22-16)13-5-7-14(8-6-13)27(21,25)26/h1-9,24H,10H2,(H2,21,25,26) |
|---|
| InChI Key | ICRSYPPLGADZKA-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Azoles |
|---|
| Sub Class | Pyrazoles |
|---|
| Direct Parent | Phenylpyrazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpyrazole
- Benzenesulfonamide
- Benzenesulfonyl group
- Benzyl alcohol
- Monocyclic benzene moiety
- Benzenoid
- Organosulfonic acid amide
- Organic sulfonic acid or derivatives
- Heteroaromatic compound
- Organosulfonic acid or derivatives
- Aminosulfonyl compound
- Sulfonyl
- Azacycle
- Alcohol
- Hydrocarbon derivative
- Primary alcohol
- Organic oxide
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Alkyl halide
- Alkyl fluoride
- Aromatic alcohol
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.93 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.8555 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.91 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 26.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1782.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 306.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 171.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 189.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 185.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 499.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 495.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 137.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1081.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 428.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1356.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 331.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 398.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 295.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 215.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 113.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Hydroxycelecoxib,1TMS,isomer #1 | C[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1 | 3192.9 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,1TMS,isomer #2 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3147.3 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,2TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO[Si](C)(C)C)C=C2)C=C1 | 3153.7 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,2TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO[Si](C)(C)C)C=C2)C=C1 | 3154.0 | Standard non polar | 33892256 | | Hydroxycelecoxib,2TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO[Si](C)(C)C)C=C2)C=C1 | 3598.0 | Standard polar | 33892256 | | Hydroxycelecoxib,2TMS,isomer #2 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3111.2 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,2TMS,isomer #2 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3323.9 | Standard non polar | 33892256 | | Hydroxycelecoxib,2TMS,isomer #2 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3868.6 | Standard polar | 33892256 | | Hydroxycelecoxib,3TMS,isomer #1 | C[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2)C=C1 | 3156.7 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,3TMS,isomer #1 | C[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2)C=C1 | 3323.9 | Standard non polar | 33892256 | | Hydroxycelecoxib,3TMS,isomer #1 | C[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2)C=C1 | 3553.1 | Standard polar | 33892256 | | Hydroxycelecoxib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1 | 3448.1 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3412.9 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 3607.5 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 3632.1 | Standard non polar | 33892256 | | Hydroxycelecoxib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 3683.0 | Standard polar | 33892256 | | Hydroxycelecoxib,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3663.2 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3741.3 | Standard non polar | 33892256 | | Hydroxycelecoxib,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1 | 3863.8 | Standard polar | 33892256 | | Hydroxycelecoxib,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 3863.3 | Semi standard non polar | 33892256 | | Hydroxycelecoxib,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 3990.4 | Standard non polar | 33892256 | | Hydroxycelecoxib,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 3660.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxycelecoxib GC-MS (Non-derivatized) - 70eV, Positive | splash10-0159-0219000000-75437073bbbdaf5d4daa | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxycelecoxib GC-MS (1 TMS) - 70eV, Positive | splash10-00ei-6219200000-3f22c3b291fe5a80e34c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxycelecoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 10V, Positive-QTOF | splash10-0002-0009000000-719c96498b40762e673f | 2016-06-20 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 20V, Positive-QTOF | splash10-0002-0019000000-35706f03cc1e8e27a4d9 | 2016-06-20 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 40V, Positive-QTOF | splash10-014j-2195000000-cbb3525c9f48b9b78c61 | 2016-06-20 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 10V, Negative-QTOF | splash10-0002-0009000000-4e2b2f45a804b673392d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 20V, Negative-QTOF | splash10-016s-1019000000-c1f5f514fa613d4f4df7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 40V, Negative-QTOF | splash10-004i-9012000000-0fdfa368188026f491e1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 10V, Positive-QTOF | splash10-0002-0009000000-2cca6189ad9818927ffd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 20V, Positive-QTOF | splash10-0002-0009000000-64b8142194a011996565 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 40V, Positive-QTOF | splash10-0ge9-0049000000-3b6aa050f18b1c799a12 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 10V, Negative-QTOF | splash10-0002-1009000000-eb5f4ee5947cfedea62a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 20V, Negative-QTOF | splash10-014j-4009000000-918311500994c904fd1c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxycelecoxib 40V, Negative-QTOF | splash10-00ou-9004000000-73d51e91d09b45542ee6 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|